share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4：持股變動聲明-董事 Borgeson Blake
美股sec公告 ·  06/14 05:40
牛牛AI助理已提取核心訊息
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on June 11, 2024. The shares were sold at a price of $8.4531 per share, resulting in a total transaction value of approximately $96,762.64. Following the transaction, Borgeson directly holds a total of 7,188,563 shares in the company. The sale was conducted in the open market.
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on June 11, 2024. The shares were sold at a price of $8.4531 per share, resulting in a total transaction value of approximately $96,762.64. Following the transaction, Borgeson directly holds a total of 7,188,563 shares in the company. The sale was conducted in the open market.
與Recursion Pharmaceuticals, Inc. [RXRX]相關聯的報告人Blake Borgeson於2024年6月11日完成了對11447股A類普通股的出售。每股售價爲$8.4531，總交易價值約爲$96762.64。交易後，Borgeson在公司中直接持有7188563股。該交易在公開市場上進行。
與Recursion Pharmaceuticals, Inc. [RXRX]相關聯的報告人Blake Borgeson於2024年6月11日完成了對11447股A類普通股的出售。每股售價爲$8.4531，總交易價值約爲$96762.64。交易後，Borgeson在公司中直接持有7188563股。該交易在公開市場上進行。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。